Meyka Pro banner
ETHK Labs Inc.

ETHK Labs Inc. (1931.HK) Stock Competitors & Peer Comparison

See (1931.HK) competitors and their performances in Stock Market.

1931.HKHKSE
HealthcareMedical - Distribution
HK$0.62
HK$0.02(3.13%)
Hong Kong Market is Open · 12:09

Peer Comparison Table: Medical - Distribution Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
1931.HKHK$0.65+1.56%1B3.27HK$0.20N/A
2607.HKHK$11.92-1.16%69.6B6.26HK$1.92+4.47%
1099.HKHK$17.21-2.33%54B6.87HK$2.52+4.56%
2192.HKHK$7.50-0.66%5.5B15.10HK$0.50+3.87%
2656.HKHK$10.12+4.01%3.5B-35.89-HK$0.28N/A
2427.HKHK$2.20+0.92%2.3B-79.33-HK$0.03N/A
2290.HKHK$3.80+1.60%1.9B0.02HK$170.43N/A
2289.HKHK$6.80-6.85%734.4M12.89HK$0.53+5.05%
9955.HKHK$0.51-1.92%335.8M-0.95-HK$0.55N/A
1298.HKHK$1.10-8.33%303M80.59HK$0.01N/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

1931.HK vs 2607.HK Comparison July 2026

1931.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1931.HK stands at 1B. In comparison, 2607.HK has a market cap of 69.6B. Regarding current trading prices, 1931.HK is priced at HK$0.65, while 2607.HK trades at HK$11.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1931.HK currently has a P/E ratio of 3.27, whereas 2607.HK's P/E ratio is 6.26. In terms of profitability, 1931.HK's ROE is +0.01%, compared to 2607.HK's ROE of +0.08%. Regarding short-term risk, 1931.HK is less volatile compared to 2607.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1931.HK.Check 2607.HK's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions